Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

Clinical trial NCT06711978 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06711978
Sponsor: Pusan National University Yangsan Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

CIPN CIPN - Chemotherapy-Induced Peripheral Neuropathy CIPN in Adjuvant Breast Cancer Patients Duloxetine Mirogabalin

Start date: 2024-12-01
Primary completion: 2025-05-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.